All lobbying filings
ARDELYX, INC.
ARDELYX, INC. filed a Q3 report for ARDELYX, INC. on October 9, 2026.
Lobbying for ARDELYX, INC.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 9, 2026
Expenses
$520,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Massachusetts
Government bodies contacted
4
Lobbying activity
1
Access, pricing and reimbursement; drug pricing issues; Medicare ESRD pharmaceutical access and reimbursement issues; ESRD benefit